UPDATE: Arix Bioscience Chair, Fosun Buy Shares As Woodford Sells (ALLISS)

21st Mar 2018 13:08

LONDON (Alliance News) - Arix Bioscience said Wednesday Fosun International Holdings Ltd and Chairman Jonathan Peacock acquired shares in the healthcare and life sciences firm as Woodford Investment Management Ltd cut its stake in separate transactions on Tuesday.

Shares in Arix were 1.9% lower at 210.00 pence on Wednesday.

Peacock acquired 90,000 shares at 225.00 pence each, worth GBP202,500. His holding after the transaction was not disclosed.

Fosun - also a life sciences firm - held 11.1 million shares in Arix after the transaction, equivalent to a 8.2% stake in the firm. The holding of Fosun prior to the transaction - if any - was not disclosed.

Fosun's buy comes shortly after it announced in late February a strategic agreement with Arix to develop and commercialise new clinical therapies for patients.

Woodford, in contrast, cut its stake to 33.1 million shares, equivalent to a 24.6% stake in the 134.8 million shares outstanding. Prior to the transaction, Woodford held a 30.7% stake in the company.

---

Related Shares:

ARIX.L